Well B101. I suppose all we can do is give management the "benefit of doubt" and hope they can get their shite together in the beginning of 2013...Disclosure.= "Still pi$$ed off...
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling